课题基金 / 基金详情

Blockade of acE and Treatment With Empagliflozin - Effects on hyperfiltratioN in Type 1 Diabetes: The BETWEEN-T1D Study

Blockade of acE and Treatment With Empagliflozin - Effects on hyperfiltratioN in Type 1 Diabetes: The BETWEEN-T1D Study
阻断 acE 和恩格列净治疗 - 对 1 型糖尿病超滤的影响:BETWEEN-T1D 研究
批准号:
304448
负责人:
Cherney David Z
金额:
$53.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-03-01 至 2018-03-01

项目摘要

项目成果

Cherney David Z的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is common for young patients with type 1 ("juvenile") diabetes (T1D) to develop high blood pressure in the kidney - a condition called "hyperfiltration". Unfortunately, hyperfiltration predisposes many of these patients to develop blood pressure proble
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SodiUm Glucose co-trAnspoRt-2 inhibitioN diabeteS And and kidney function Loss in Type 1 diabetes: The "SUGARNSALT" Team Grant Program
  • 批准号:
    454370
  • 项目类别:
    Operating Grants
  • 资助金额:
    $72.32万
  • 财政年份:
    2021
  • 负责人:
    Cherney David Z
  • 依托单位:
SodiUm Glucose co-trAnspoRt-2 inhibitioN diabeteS And and kidney function Loss in Type 1 diabetes: The "SUGARNSALT" Team Grant Program
  • 批准号:
    446716
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.73万
  • 财政年份:
    2020
  • 负责人:
    Cherney David Z
  • 依托单位:
A Deep Phenotyping Approach to Assess the Effect of Uric Acid Lowering in Patients with Uncomplicated Type 1 Diabetes Mellitus
  • 批准号:
    279793
  • 项目类别:
    Operating Grants
  • 资助金额:
    $24.12万
  • 财政年份:
    2013
  • 负责人:
    Cherney David Z
  • 依托单位:
海外基金